NASDAQ:CATB
Delisted
Catabasis Pharmaceuticals Stock News
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Oppenheimer Remains a Buy on aTyr Pharma (LIFE)
10:44am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on aTyr Pharma (LIFE) today and set a price target of $8.00. The company's shares closed last
Oppenheimer Remains a Buy on aTyr Pharma (LIFE)
10:44am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on aTyr Pharma (LIFE – Research Report) today and set a price
Wedbush Sticks to Their Hold Rating for Omeros (OMER)
06:13pm, Monday, 27'th Apr 2020
In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Omeros (OMER), with a price target of $17.00. The company's shares
Wedbush Sticks to Their Hold Rating for Omeros (OMER)
06:13pm, Monday, 27'th Apr 2020
In a report released today,
Liana Moussatos
from Wedbush reiterated a
Hold
rating on Omeros (
OMER
–
Research Report
), with a price target of
$17.00
. The company’s shares closed last Monday at $
Pacira Pharmaceuticals (PCRX) Gets a Buy Rating from Wedbush
06:10pm, Monday, 27'th Apr 2020
Wedbush analyst Liana Moussatos reiterated a Buy rating on Pacira Pharmaceuticals (PCRX) today and set a price target of $85.00. The company's shares
Dietary supplements may help fight off viral diseases like COVID-19: Study
12:06pm, Monday, 27'th Apr 2020
Vitamin C, vitamin D, zinc, and an omega-3 fatty acid found in fish, docosahexaenoic acid (DHA), are particularly critical for immune function, according to the researchers, including those from Unive
Wedbush Maintains a Buy Rating on Intercept Pharma (ICPT)
07:55am, Monday, 27'th Apr 2020
In a report issued on April 24, Liana Moussatos from Wedbush maintained a Buy rating on Intercept Pharma (ICPT), with a price target of $257.00. The
Wedbush Maintains a Buy Rating on Intercept Pharma (ICPT)
07:55am, Monday, 27'th Apr 2020
In a report issued on April 24,
Liana Moussatos
from Wedbush maintained a
Buy
rating on Intercept Pharma (
ICPT
–
Research Report
), with a price target of
$257.00
. The company’s shares closed la
Catabasis Pharmaceuticals (CATB) Receives a Buy from Oppenheimer
02:12am, Monday, 27'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Catabasis Pharmaceuticals (CATB) yesterday and set a price target of $60.00. The company's
Aimmune Therapeutics (AIMT) Gets a Buy Rating from Wedbush
10:16am, Friday, 24'th Apr 2020
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aimmune Therapeutics (AIMT), with a price target of $66.00. The
Aimmune Therapeutics (AIMT) Gets a Buy Rating from Wedbush
10:16am, Friday, 24'th Apr 2020
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aimmune Therapeutics (AIMT – Research Report),
KPK panggil mantan Kalapas Sukamiskin Deddy Handoko sebagai tersangka
03:54am, Friday, 24'th Apr 2020
Komisi Pemberantasan Korupsi (KPK), Jumat memanggil mantan Kepala Lembaga Pemasyarakatan (Kalapas) Klas I Sukamiskin Bandung Deddy Handoko (DHA) dalam ...
Best at home fake tanning sprays, mousses, gel and cream to fake a holiday glow
01:48pm, Thursday, 23'rd Apr 2020
Even though we’d rather get a tan whilst strolling along the beach or lying in a lounger on the beach, these will help you fake it until you can
Intercept Pharma (ICPT) Gets a Buy Rating from Wedbush
07:57am, Wednesday, 22'nd Apr 2020
In a report issued on April 17, Liana Moussatos from Wedbush maintained a Buy rating on Intercept Pharma (ICPT), with a price target of $257.00. The
Intercept Pharma (ICPT) Gets a Buy Rating from Wedbush
07:57am, Wednesday, 22'nd Apr 2020
In a report issued on April 17, Liana Moussatos from Wedbush maintained a Buy rating on Intercept Pharma (ICPT –
